Many researchers through retrospective analysis found some related markers to ChRCC, such as c-Met [5], PD-L2 [6], and the oncogene KIT expression [7], which were almost upregulated, associated with metastatic progression and poor survival in ChRCC. This evidence concerns the gene PDCD1LG2 and chromophobe renal cell carcinoma.